XML 42 R30.htm IDEA: XBRL DOCUMENT

Stock-based Compensation (Tables)

9 Months Ended

Apr. 30, 2022

The following is a summary of activity for the Company’s stock options for the nine months ended April 30, 2022:


(In thousands, except per share and term data)	Shares	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (In years)	Aggregate Intrinsic Value
Outstanding as of July 31, 2021	6,427	$	50.69	5.69	$	619,019
Grants of options	340	133.96
Exercises	(525)	30.67
Forfeitures or expirations	(165)	56.11
Outstanding as of April 30, 2022	6,077	$	56.93	5.48	$	351,978
Exercisable as of April 30, 2022	4,429	$	44.46	4.59	$	308,452

The following is a summary of activity for the Company’s stock option awards subject to market conditions for the nine months ended April 30, 2022:


(In thousands, except per share and term data)	Shares	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (In years)	Aggregate Intrinsic Value
Outstanding as of July 31, 2021	1,130	$	87.49	8.96	$	67,250
Grants of options	325	125.68
Exercises	—	—
Forfeitures or expirations	—	—
Outstanding as of April 30, 2022	1,455	$	96.02	8.59	$	29,564
Exercisable as of April 30, 2022	395	$	86.56	8.17	$	10,697

The table below sets forth the stock-based compensation recognized by the Company for stock options, restricted stock, and restricted unit awards:


	Three Months Ended April 30,				Nine Months Ended April 30,
(In thousands)	2022		2021		2022		2021
General and administrative	$	8,401	$	7,966	$	25,119	$	22,399
Yard operations	1,417		1,401		3,813		4,746
Total stock-based compensation	$	9,818	$	9,367	$	28,932	$	27,145

The following is a summary of activity for the Company’s RSA’s and RSU’s for the nine months ended April 30, 2022:


(In thousands, except per share data)	Restricted Shares	Weighted Average Grant Date Fair Value
Outstanding as of July 31, 2021	102	$	90.46
Grants	141	133.60
Vested	(22)	74.24
Forfeitures or expirations	(13)	107.05
Outstanding as of April 30, 2022	208	$	120.50